tiprankstipranks
Trending News
More News >
Immuno-Biological Laboratories Co., Ltd. (JP:4570)
:4570
Japanese Market

Immuno-Biological Laboratories Co., Ltd. (4570) Financial Statements

Compare
0 Followers

Immuno-Biological Laboratories Co., Ltd. Financial Overview

Immuno-Biological Laboratories Co., Ltd.'s market cap is currently ¥14.31B. The company's EPS TTM is ¥8.67; its P/E ratio is 44.82; Immuno-Biological Laboratories Co., Ltd. is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 969.53M¥ 816.70M¥ 794.62M¥ 647.58M¥ 602.75M
Gross Profit¥ 628.34M¥ 517.29M¥ 526.71M¥ 376.70M¥ 346.86M
Operating Income¥ 209.35M¥ 104.30M¥ 58.37M¥ -122.22M¥ -240.98M
EBITDA¥ 226.55M¥ 128.11M¥ -332.00M¥ -249.50M¥ -309.88M
Net Income¥ 249.05M¥ 186.69M¥ -289.73M¥ -258.77M¥ -318.83M
Balance Sheet
Cash & Short-Term Investments¥ 825.73M¥ 734.14M¥ 614.16M¥ 508.35M¥ 604.19M
Total Assets¥ 1.85B¥ 1.62B¥ 1.43B¥ 1.71B¥ 1.84B
Total Debt¥ 204.23M¥ 235.98M¥ 234.99M¥ 234.00M¥ 90.00M
Net Debt¥ -621.50M¥ -498.15M¥ -379.17M¥ -274.35M¥ -514.19M
Total Liabilities¥ 331.03M¥ 353.27M¥ 355.72M¥ 336.99M¥ 208.76M
Stockholders' Equity¥ 1.51B¥ 1.27B¥ 1.08B¥ 1.37B¥ 1.63B
Cash Flow
Free Cash Flow¥ 123.83M¥ 115.11M¥ 26.46M¥ -93.20M¥ -207.60M
Operating Cash Flow¥ 183.50M¥ 133.78M¥ 26.46M¥ -93.20M¥ -194.15M
Investing Cash Flow¥ -53.66M¥ -24.50M¥ 30.04M¥ -155.63M¥ -17.23M
Financing Cash Flow¥ -31.75M¥ 991.00K¥ 991.00K¥ 144.00M¥ -216.00M
Currency in JPY

Immuno-Biological Laboratories Co., Ltd. Earnings and Revenue History

Immuno-Biological Laboratories Co., Ltd. Debt to Assets

Immuno-Biological Laboratories Co., Ltd. Cash Flow

Immuno-Biological Laboratories Co., Ltd. Forecast EPS vs Actual EPS